Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels.

The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.

Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares for a maximum amount of 50,000,000 Euro on its behalf under the terms of an initial discretionary mandate agreement with validity until March 31, 2022, effective as from April 1, 2021.

On April 23, 2021, the Agfa-Gevaert Group held 524,502 own shares, which represents 0.31% of the total number of shares of the Group.

Detailed operations per day:

Date

Number of shares Average price (€) Minimum price (€) Maximum price (€)

Total price (€)

April 19, 2021

23,860 4.0822 4.0450 4.0950   97,401.29

April 20, 2021

26,528 4.0957 4.0600 4.1150 108,650.73

April 21, 2021

29,443 4.1436 4.1100 4.1650

122,000.01

April 22, 2021 25,254 4.1508 4.1400 4.1700

104,824.30

April 23, 2021 31,624 4.1317 4.1100 4.1500  130,660.88
Total 136,709 4.1208

563,537.22

About Agfa

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2020, the Group realized a turnover of 1,709 million Euro.

Contact:

Viviane Dictus
Director Corporate Communication
T +32 (0) 3 444 71 24
E viviane.dictus@agfa.com

 

Johan Jacobs

Corporate Press Relations Manager
T +32 (0)3/444 80 15

E johan.jacobs@agfa.com